Financial statements Bio-Rol
Balance sheet data of BIO-ROL
Year
|
2022
|
2023
|
---|---|---|
Total assets | 4 060 070,70 | 3 072 501,32 |
A. Fixed assets | 1 059 766,47 | 1 121 067,20 |
B. Current assets | 3 000 304,23 | 1 951 434,12 |
C. Share capital contributions (basic funds) | - | - |
D. Own shares (stocks) | - | - |
Total liabilities | 4 060 070,70 | 3 072 501,32 |
A. Equity | -1 999 885,15 | 287 686,89 |
B. Liabilities and provisions for liabilities | 6 059 955,85 | 2 784 814,43 |
I. Long-term liabilities | 1 476 000,00 | 1 551 821,77 |
II. Short-term liabilities | 4 583 955,85 | 1 232 992,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.